Total Funding
42
47
Total FundingPost-IPO Debt raised
Growth Score
-1 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
150797
Cyclo Therapeutics is a clinical-stage biotechnology company that focuses on the use of cyclodextrins in drug development.
Jeffrey L. Tate: Director, Chief Operating Officer and Chief Quality Officer- N. Scott Fine: Chairman of the Board and Chief Executive Officer
Rafael Holdings
About the Company
Cyclo Therapeutics is a clinical-stage biotechnology company focused on the use of cyclodextrins in drug development.
